Serotonin-induced constriction of ocular arteries in atherosclerotic monkeys: Implications for ischemic disorders of the retina and optic nerve head

Archives of Ophthalmology

Volumn 115, Issue 2, 1997, Pages 220-228

  Hayreh, Sohan Singh ^a   Piegors, Donald J ^a   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CENTRAL RETINA ARTERY OCCLUSION; CILIARY ARTERY; CONTROLLED STUDY; ISCHEMIC OPTIC NEUROPATHY; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINA ISCHEMIA;

EID: 8044225292     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150222012     Document Type: Article

References (32)

1. Hayreh SS. Progress in the understanding of the vascular etiology of glaucoma. Curr Opin Opthalmol. 1994;5(11):26-35.
2. Hayreh SS, Podhajsky P. Ocular neovascularization with retinal vascular occlusion, II: occurrence in central and branch retinal artery occlusion. Arch Ophthalmol. 1982;100:1585-1596.
3. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994; 118:766-780.
4. Faraci FM, Armstrong ML, Heistad DD. Dietary treatment of atherosclerosis abolishes hyperresponsiveness of retinal blood vessels to serotonin in monkeys. Stroke. 1991;22:1405-1408.
5. Sobey CY, Faraci FM, Piegors DJ, Heistad DD. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries. Stroke. 1996; 27:927-933.
6. Henry PD, Yokoyama M. Supersensitivity of atherosclerotic rabbit aorta to ergonovine: mediation by a serotonergic mechanism. J Clin Invest. 1980;66:306-313.
7. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984;54:711-718.
8. Vanhoutte PM, Houston DS. Platelets, endothelium and vasospasm. Circulation. 1985;72:728-734.
9. Heistad DD, Mark AL, Marcus ML, Piegors DJ, Armstrong ML. Dietary treatment of atherosclerosis abolishes hyperresponsiveness to serotonin: implications for vasospasm. Circ Res. 1987;61:346-351.
10. Heistad DD. Breese K, Armstrong ML. Cerebral vasoconstrictor responses to serotonin after dietary treatment of atherosclerosis: implications for transient ischemic attacks. Stroke. 1987;18:1068-1073.
11. Faraci FM, Williams JK, Breese KR, Armstrong ML, Heistad DD. Atherosclerosis potentiates constrictor responses of cerebral and ocular blood vessels to thromboxane in monkeys. Stroke. 1989;20:242-247.
12. Faraci FM, Lopez JAG, Breese K, Armstrong ML, Heistad DD. Effect of atherosclerosis on cerebral vascular responses to activation of leukocytes and platelets in monkeys. Stroke. 1991;22:790-796.
13. Benzuly KH, Padgett RC, Kaul S, Piegors DJ, Armstrong ML, Heistad DD. Functional improvement precedes structural regression of atherosclerosis. Circulation. 1994;89:1810-1818.
14. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res. 1986;58:783-789.
15. Tagawa H, Tomoike H, Nakamura M. Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ Res. 1991;68:330-337.
16. Golino P, Piscione F, Willerson JT, et al. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 1991;324:641-648.
17. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med. 1991;324:648-654.
18. Armstrong ML, Warner ED, Connor WE. Regression of coronary atheromatosis in rhesus monkeys. Circ Res. 1970;27:59-67.
19. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987; 80:1808-1811.
20. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet. 1993;341:1496-1500.
21. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK. Physiochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest. 1984;73:1590-1605.
22. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
23. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
24. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
25. Heistad DD, Armstrong ML. Sick vessel syndrome: can atherosclerotic arteries recover? Circulation. 1994;89:2447-2450.
26. Williams JK, Baumbach GL, Armstrong ML, Heistad DD. Hypothesis: vasoconstriction contributes to amaurosis fugax. J Cereb Blood Flow Metab. 1989;9:111-116.
27. Hayreh SS. Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations, and management. Ophthalmol Clin North Am. 1996;9:407-442.
28. Hayreh SS. Vasospasm and transient monocular blindness. N Engl J Med. 1992; 326:837-838.
29. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology. 1980;87:75-78.
30. Hayreh SS, Weingeist TA. Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Br J Ophthalmol. 1980; 64:818-825.
31. Hayreh SS. Anterior ischemic optic neuropathy. Arch Neurol. 1981;38:675-678.
32. Hayreh SS, Zimmerman MB, Podhajsky PA, Alward WLM. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603-624.